ArticleAntimicrobial agents and chemotherapy2020

An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline.

Steven J Kovacs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.